Vaccine Ontology
578 terms(s) returned
| Term Type: Class | Record: 501 to 550 of 578 Records | Page: 11 of 12, First Previous Next Last | Show Records Per Page |
- apxIIIB from Actinobacillus pleuropneumoniae
- apxIIID from Actinobacillus pleuropneumoniae
- apxIVA from Actinobacillus pleuropneumoniae
- arlacel A vaccine adjuvant
- aroA from Aeromonas hydrophila
- aroA from Aeromonas salmonicida
- aroA from Bordetella bronchiseptica
- aroA from Bordetella pertussis
- aroA from Mannheimia haemolytica
- aroA from Pasteurella multocida
- aroA from Salmonella Typhi
- aroA from Shigella
- aroA from Staphylococcus aureus
- aroA from Yersinia enterocolitica
- aroA from Yersinia ruckeri
- aroC from Burkholderia pseudomallei
- aroC from Edwardsiella tarda
- aroC from Salmonella Typhi
- aroD from Salmonella Typhi
- aroD from Shigella
- arthritis vaccine
- asd from Burkholderia pseudomallei
- asd from Salmonella Typhimurium
- asp24 from B. abortus
- aspartame
- assay
- assay measurement sample interval
- assay analysis tool version datum
- assay analysis tool version variable
- assay mesurement datum
- assay mesurement variable
- assay objective
- assay of CFU reduction in liver
- assay of CFU reduction in lung
- assay of CFU reduction in spleen
- assay platform datum
- assay platform variable
- assay sample endpoint variable
- assay sample source variable
- assay type datum
- assay type variable
- atherosclerosis vaccine
- atpA from Salmonella Typhimurium
- attenuated Brucella abortus with deletion of znuA
- attenuated Listeria expressing cancer antigen vaccine
- attenuated M. bovis strain WAg520
- attenuated M. bovis strain WAg522
- attenuated M. bovis strain WAg539
- augmented protection and cellular immunity using host protein as adjuvant
- authorized COVID-19 DNA vaccine
